clarithromycin has been researched along with Critical Illness in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, YW; Jeon, SC; Kim, H; Kim, TH; Paik, SS; Park, DW; Park, SS; Shon, JW; Yoon, HJ | 1 |
Beitz, A; Ehmer, U; Eser, S; Fekecs, L; Huber, W; Lahmer, T; Messer, M; Schmid, RM | 1 |
2 other study(ies) available for clarithromycin and Critical Illness
Article | Year |
---|---|
Near fatal desquamative interstitial pneumonia with bilateral recurrent tension pneumothorax.
Topics: Adult; Biopsy, Needle; Clarithromycin; Combined Modality Therapy; Critical Illness; Disease Progression; Follow-Up Studies; Genetic Diseases, Inborn; Humans; Lung Diseases, Interstitial; Male; Multidetector Computed Tomography; Pneumothorax; Prednisolone; Rare Diseases; Recurrence; Risk Assessment; Thoracic Surgery, Video-Assisted; Treatment Outcome | 2015 |
Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; beta-Glucans; Clarithromycin; Coinfection; Critical Illness; Extracorporeal Membrane Oxygenation; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Linezolid; Male; Mannans; Meropenem; Pneumonia; Pseudallescheria; Severe Acute Respiratory Syndrome; Thienamycins; Transplant Recipients; Voriconazole | 2016 |